biotech Β· Advanced Solid Tumors Β· Seasonal Allergic Rhinitis Β· PRME
Prime Medicine
Prime Medicine trial registry β 17 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- 60 First St, Cambridge, Massachusetts 02141, US
- Founded
- 2019
- Employees
- 185
- Programs
- 17
- Drugs
- 6
- Patents
- 127
Prime Medicine clinical trials
Registry index of 17 ClinicalTrials.gov studies linked to Prime Medicine programs β each row shows trial ID, program name, phase, status, and indication.
Prime Medicine trial registry β 17 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Prime Medicine.
-
Recommended treatment schedule β Phase 3
Clinical update -
PG-011 nasal spray 0.6%(twice daily) β Phase 3
Clinical update -
Pumecitinib Nasal Spray 0.3% β Phase 2
Clinical update -
Bemarituzumab β Phase 1
Clinical update -
Artificial intelligence in diagnosis β Unknown
Clinical update -
PG-011Gel β Phase 3
Clinical update -
Bemarituzumab β Phase 2
Clinical update -
FP-1039 β Phase 2
Clinical update